Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Impact of COVID-19 on chronic migraine treated with erenumab: a case report.

< BACK TO ARCHIVE


2021 May 21


Neurol Sci


http://www.ncbi.nlm.nih.gov/pubmed/34021438?dopt=Abstract

Impact of COVID-19 on chronic migraine treated with erenumab: a case report.

Authors

Impact of COVID-19 on chronic migraine treated with erenumab: a case report.
Grassini A, Marcinnò A, Roveta F, Gallo E, Cermelli A, Boschi S, Rubino E, Rainero I
Neurol Sci. 2021 May 21.
PMID: 34021438.

Abstract

Headache is a frequent symptom of the novel coronavirus 19 disease (COVID-19). To date, there are limited information on how COVID-19 affects migraine and its treatment.
Read This Paper